{"id":32651,"date":"2023-10-17T06:08:38","date_gmt":"2023-10-17T06:08:38","guid":{"rendered":"https:\/\/www.process.st\/templates\/clinical-development-plan-fda\/"},"modified":"2024-03-05T14:38:35","modified_gmt":"2024-03-05T14:38:35","slug":"clinical-development-plan-fda","status":"publish","type":"post","link":"https:\/\/www.process.st\/templates\/clinical-development-plan-fda\/","title":{"rendered":"Clinical Development Plan FDA"},"content":{"rendered":"\n<section id=\"identify-target-disease-indication\"> \n <h2>Identify target disease indication<\/h2>\n <div class=\"text-content\">\n   This task involves identifying the specific disease or condition that the clinical development plan will target. The goal is to determine the area of focus for the plan, which will guide the rest of the process. Consider the impact of choosing the right disease indication, the potential benefits to patients, and the alignment with the company's goals. Are there any challenges in identifying the target disease indication? How can these challenges be overcome? \n <\/div> \n <div class=\"text-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Target Disease Indication <\/label> \n   <input type=\"text\" placeholder=\"Something will be typed here...\" disabled class=\"form-control\"> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"conduct-literature-review-on-target-indication\"> \n <h2>Conduct literature review on target indication<\/h2>\n <div class=\"text-content\">\n   In this task, a thorough literature review will be conducted to gather information on the target disease indication. The purpose of this review is to gain a comprehensive understanding of the current knowledge, existing research, and treatment options related to the target indication. How will this literature review impact the clinical development plan? What specific aspects should be focused on during the review? How can any potential challenges in accessing relevant literature be addressed? Resources or tools that may be helpful for this task include medical databases, research articles, and expert opinions. \n <\/div> \n <div class=\"textarea-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Literature review findings <\/label> <textarea placeholder=\"Something will be typed here...\" rows=\"3\" disabled class=\"form-control\"><\/textarea> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"assemble-project-team\"> \n <h2>Assemble project team<\/h2>\n <div class=\"text-content\">\n   This task involves assembling a project team that will be responsible for the successful implementation of the clinical development plan. The team should consist of individuals with diverse expertise and skills related to clinical research, regulatory affairs, data analysis, and medical writing. What roles and responsibilities should be assigned to different team members? How will the composition of the project team impact the overall success of the plan? What challenges may arise in assembling the team and how can they be addressed? Resources or tools that may be helpful for this task include human resources databases, professional networks, and project management software. \n <\/div> \n <div class=\"multi-select-content form-field-content\"> \n  <div class=\"form-group\"> <label> Team members <\/label> \n  <\/div> \n  <ul class=\"items\"> \n   <li class=\"item\"> \n    <div class=\"step-number-container\"> \n     <div class=\"step-number\">\n       1 \n     <\/div> \n    <\/div> \n    <div class=\"step-checkbox-container\"> \n     <div class=\"step-checkbox\"><\/div> \n    <\/div> \n    <div class=\"item-name-static\">\n      Clinical research coordinator \n    <\/div> <\/li>\n   <li class=\"item\"> \n    <div class=\"step-number-container\"> \n     <div class=\"step-number\">\n       2 \n     <\/div> \n    <\/div> \n    <div class=\"step-checkbox-container\"> \n     <div class=\"step-checkbox\"><\/div> \n    <\/div> \n    <div class=\"item-name-static\">\n      Regulatory affairs specialist \n    <\/div> <\/li>\n   <li class=\"item\"> \n    <div class=\"step-number-container\"> \n     <div class=\"step-number\">\n       3 \n     <\/div> \n    <\/div> \n    <div class=\"step-checkbox-container\"> \n     <div class=\"step-checkbox\"><\/div> \n    <\/div> \n    <div class=\"item-name-static\">\n      Data analyst \n    <\/div> <\/li>\n   <li class=\"item\"> \n    <div class=\"step-number-container\"> \n     <div class=\"step-number\">\n       4 \n     <\/div> \n    <\/div> \n    <div class=\"step-checkbox-container\"> \n     <div class=\"step-checkbox\"><\/div> \n    <\/div> \n    <div class=\"item-name-static\">\n      Medical writer \n    <\/div> <\/li> \n  <\/ul> \n <\/div> \n<\/section> \n<section id=\"develop-clinical-trial-concept\"> \n <h2>Develop clinical trial concept<\/h2>\n <div class=\"text-content\">\n   In this task, the clinical trial concept will be developed based on the identified target disease indication and literature review findings. The concept should outline the specific objectives, study design, patient population, and endpoints of the clinical trial. What key aspects should be considered when developing the clinical trial concept? How will this concept guide the subsequent steps in the clinical development plan? What challenges may arise in developing the concept and how can they be addressed? Resources or tools that may be helpful for this task include regulatory guidelines, previous clinical trial protocols, and expert opinions. \n <\/div> \n <div class=\"textarea-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Clinical trial concept <\/label> <textarea placeholder=\"Something will be typed here...\" rows=\"3\" disabled class=\"form-control\"><\/textarea> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"approval-clinical-trial-concept\"> \n <h2>Approval: Clinical Trial Concept<\/h2>\n <div class=\"approval-content\"> \n  <div class=\"header\"> \n   <div class=\"list-title\">\n    Will be submitted for approval:\n   <\/div> \n  <\/div> \n  <div class=\"approval-rule-subject-tasks-list\"> \n   <ul class=\"list\"> \n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Develop clinical trial concept<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li> \n   <\/ul> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"design-preliminary-trial-protocol\"> \n <h2>Design preliminary trial protocol<\/h2>\n <div class=\"text-content\">\n   This task involves designing a preliminary trial protocol based on the developed clinical trial concept. The protocol should provide detailed information on the study design, inclusion and exclusion criteria, study procedures, data collection methods, and statistical analysis plan. What specific considerations should be taken into account when designing the preliminary trial protocol? How will this protocol contribute to the overall success of the clinical development plan? What challenges may arise in designing the protocol and how can they be addressed? Resources or tools that may be helpful for this task include regulatory guidelines, previous clinical trial protocols, and statistical analysis software. \n <\/div> \n <div class=\"textarea-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Preliminary trial protocol <\/label> <textarea placeholder=\"Something will be typed here...\" rows=\"3\" disabled class=\"form-control\"><\/textarea> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"conduct-preind-meeting-with-fda\"> \n <h2>Conduct pre-IND meeting with FDA<\/h2>\n <div class=\"text-content\">\n   In this task, a pre-IN, meeting will be conducted with the FDA to discuss the IND application and gather feedback on the proposed clinical trial. The meeting is an opportunity to address any concerns or questions raised by the FDA and ensure alignment between the development plan and regulatory requirements. What specific objectives should be achieved during the pre-IND meeting? How will the meeting impact the subsequent steps in the clinical development plan? What challenges may arise during the meeting and how can they be addressed? Resources or tools that may be helpful for this task include FDA guidelines, previous meeting minutes, and expert opinions. \n <\/div> \n <div class=\"date-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Pre-IND meeting date <\/label> \n   <div class=\"date-container\"> <button type=\"button\" disabled class=\"btn btn-default\"> <i class=\"fa fa-calendar btn-icon\"><\/i> Date will be set here <\/button> \n   <\/div> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"approval-preind-meeting-outcomes\"> \n <h2>Approval: Pre-IND Meeting outcomes<\/h2>\n <div class=\"approval-content\"> \n  <div class=\"header\"> \n   <div class=\"list-title\">\n    Will be submitted for approval:\n   <\/div> \n  <\/div> \n  <div class=\"approval-rule-subject-tasks-list\"> \n   <ul class=\"list\"> \n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Conduct pre-IND meeting with FDA<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li> \n   <\/ul> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"prepare-ind-application\"> \n <h2>Prepare IND application<\/h2>\n <div class=\"text-content\">\n   This task involves preparing the IND (Investigational New Drug) application, which is a comprehensive document that provides detailed information about the proposed clinical trial to the FDA. The application includes the clinical trial protocol, manufacturing information, preclinical data, and plans for patient safety monitoring. What specific components should be included in the IND application? How will the quality and completeness of this application impact the FDA's review process? What challenges may arise when preparing the IND application and how can they be addressed? Resources or tools that may be helpful for this task include FDA guidelines, previous IND applications, and expert opinions. \n <\/div> \n <div class=\"file-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> IND application document <\/label> \n   <div class=\"file-container\"> <button type=\"button\" disabled class=\"btn btn-default\"> <i class=\"fa fa-upload btn-icon\"><\/i> File will be uploaded here <\/button> \n   <\/div> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"submit-ind-application-to-fda\"> \n <h2>Submit IND application to FDA<\/h2>\n <div class=\"text-content\">\n   In this task, the prepared IND application will be submitted to the FDA for review. The submission should follow the required format and include all necessary supporting documents. How should the IND application be submitted to the FDA? What happens after the submission? What challenges may arise during the submission process and how can they be addressed? Resources or tools that may be helpful for this task include FDA guidelines, previous IND submissions, and expert opinions. \n <\/div> \n <div class=\"date-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> IND application submission date <\/label> \n   <div class=\"date-container\"> <button type=\"button\" disabled class=\"btn btn-default\"> <i class=\"fa fa-calendar btn-icon\"><\/i> Date will be set here <\/button> \n   <\/div> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"address-any-fda-questions-regarding-ind-application\"> \n <h2>Address any FDA questions regarding IND application<\/h2>\n <div class=\"text-content\">\n   This task involves addressing any questions or requests for additional information raised by the FDA during the review of the IND application. Prompt and thorough responses are essential to ensure a smooth review process. What potential questions or requests may be raised by the FDA? How should these questions be addressed? What challenges may arise when responding to FDA questions and how can they be addressed? Resources or tools that may be helpful for this task include FDA guidelines, previous FDA correspondence, and expert opinions. \n <\/div> \n <div class=\"textarea-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> FDA questions response <\/label> <textarea placeholder=\"Something will be typed here...\" rows=\"3\" disabled class=\"form-control\"><\/textarea> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"receive-fda-approval-for-ind-application\"> \n <h2>Receive FDA approval for IND application<\/h2>\n <div class=\"text-content\">\n   In this task, the FDA's decision regarding the IND application will be received. The approval allows the clinical trial to proceed, while any requests for additional information or concerns raised by the FDA need to be addressed before the trial can move forward. What specific outcomes can arise from the FDA's review of the IND application? How will the decision impact the subsequent steps in the clinical development plan? What challenges may arise in receiving FDA approval and how can they be addressed? Resources or tools that may be helpful for this task include FDA guidelines, previous FDA correspondence, and expert opinions. \n <\/div> \n <div class=\"select-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> FDA's decision <\/label> <select disabled class=\"form-control\"> <option value=\"An option will be selected here\">An option will be selected here<\/option> <\/select> \n  <\/div> \n  <ul class=\"items\"> \n   <li class=\"item\"> \n    <div class=\"step-number-container\"> \n     <div class=\"step-number\">\n       1 \n     <\/div> \n    <\/div> \n    <div class=\"step-checkbox-container\"> \n     <div class=\"step-checkbox\"><\/div> \n    <\/div> \n    <div class=\"item-name-static\">\n      Approval \n    <\/div> <\/li>\n   <li class=\"item\"> \n    <div class=\"step-number-container\"> \n     <div class=\"step-number\">\n       2 \n     <\/div> \n    <\/div> \n    <div class=\"step-checkbox-container\"> \n     <div class=\"step-checkbox\"><\/div> \n    <\/div> \n    <div class=\"item-name-static\">\n      Requests for additional information \n    <\/div> <\/li>\n   <li class=\"item\"> \n    <div class=\"step-number-container\"> \n     <div class=\"step-number\">\n       3 \n     <\/div> \n    <\/div> \n    <div class=\"step-checkbox-container\"> \n     <div class=\"step-checkbox\"><\/div> \n    <\/div> \n    <div class=\"item-name-static\">\n      Concerns raised \n    <\/div> <\/li> \n  <\/ul> \n <\/div> \n<\/section> \n<section id=\"prepare-for-phase-1-trial\"> \n <h2>Prepare for Phase 1 trial<\/h2>\n <div class=\"text-content\">\n   This task focuses on preparing for the Phase 1 clinical trial, which involves testing the investigational drug or treatment on a small group of healthy volunteers or individuals with the target disease indication. The preparations include finalizing the study protocol, recruiting participants, and ensuring the necessary resources are in place. What specific preparations should be made for the Phase 1 trial? How will these preparations impact the overall success of the trial? What challenges may arise in preparing for the Phase 1 trial and how can they be addressed? Resources or tools that may be helpful for this task include clinical trial protocols, recruitment strategies, and expert opinions. \n <\/div> \n <div class=\"date-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Phase 1 trial start date <\/label> \n   <div class=\"date-container\"> <button type=\"button\" disabled class=\"btn btn-default\"> <i class=\"fa fa-calendar btn-icon\"><\/i> Date will be set here <\/button> \n   <\/div> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"conduct-phase-1-trial\"> \n <h2>Conduct Phase 1 trial<\/h2>\n <div class=\"text-content\">\n   In this task, the Phase 1 clinical trial will be conducted according to the finalized protocol. The trial aims to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the investigational drug or treatment. How will the Phase 1 trial be conducted? What specific procedures and assessments will be performed? What challenges may arise during the trial and how can they be addressed? Resources or tools that may be helpful for this task include clinical trial protocols, data collection forms, and expert opinions. \n <\/div> \n <div class=\"date-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Phase 1 trial end date <\/label> \n   <div class=\"date-container\"> <button type=\"button\" disabled class=\"btn btn-default\"> <i class=\"fa fa-calendar btn-icon\"><\/i> Date will be set here <\/button> \n   <\/div> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"analyze-phase-1-trial-data\"> \n <h2>Analyze Phase 1 trial data<\/h2>\n <div class=\"text-content\">\n   This task involves analyzing the data collected during the Phase 1 trial to evaluate the safety, tolerability, and pharmacokinetic profile of the investigational drug or treatment. The analysis should be conducted using appropriate statistical methods and should provide valuable insights for the subsequent phases of the clinical development plan. How will the Phase 1 trial data be analyzed? What specific endpoints and measures will be assessed? What challenges may arise during the data analysis and how can they be addressed? Resources or tools that may be helpful for this task include statistical analysis software, data visualization tools, and expert opinions. \n <\/div> \n <div class=\"textarea-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Phase 1 trial data analysis <\/label> <textarea placeholder=\"Something will be typed here...\" rows=\"3\" disabled class=\"form-control\"><\/textarea> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"approval-phase-1-trial-data\"> \n <h2>Approval: Phase 1 Trial Data<\/h2>\n <div class=\"approval-content\"> \n  <div class=\"header\"> \n   <div class=\"list-title\">\n    Will be submitted for approval:\n   <\/div> \n  <\/div> \n  <div class=\"approval-rule-subject-tasks-list\"> \n   <ul class=\"list\"> \n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Conduct Phase 1 trial<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li>\n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Analyze Phase 1 trial data<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li> \n   <\/ul> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"prepare-for-phase-2-trial\"> \n <h2>Prepare for Phase 2 trial<\/h2>\n <div class=\"text-content\">\n   This task focuses on preparing for the Phase 2 clinical trial, which involves testing the investigational drug or treatment on a larger group of participants with the target disease indication. The preparations include finalizing the study protocol, recruiting participants, and ensuring the necessary resources are in place. What specific preparations should be made for the Phase 2 trial? How will these preparations impact the overall success of the trial? What challenges may arise in preparing for the Phase 2 trial and how can they be addressed? Resources or tools that may be helpful for this task include clinical trial protocols, recruitment strategies, and expert opinions. \n <\/div> \n <div class=\"date-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Phase 2 trial start date <\/label> \n   <div class=\"date-container\"> <button type=\"button\" disabled class=\"btn btn-default\"> <i class=\"fa fa-calendar btn-icon\"><\/i> Date will be set here <\/button> \n   <\/div> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"conduct-phase-2-trial\"> \n <h2>Conduct Phase 2 trial<\/h2>\n <div class=\"text-content\">\n   In this task, the Phase 2 clinical trial will be conducted according to the finalized protocol. The trial aims to evaluate the efficacy and safety of the investigational drug or treatment in a larger group of participants with the target disease indication. How will the Phase 2 trial be conducted? What specific procedures, assessments, and endpoints will be used? What challenges may arise during the trial and how can they be addressed? Resources or tools that may be helpful for this task include clinical trial protocols, data collection forms, and expert opinions. \n <\/div> \n <div class=\"date-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Phase 2 trial end date <\/label> \n   <div class=\"date-container\"> <button type=\"button\" disabled class=\"btn btn-default\"> <i class=\"fa fa-calendar btn-icon\"><\/i> Date will be set here <\/button> \n   <\/div> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"analyze-phase-2-trial-data\"> \n <h2>Analyze Phase 2 trial data<\/h2>\n <div class=\"text-content\">\n   This task involves analyzing the data collected during the Phase 2 trial to evaluate the efficacy, safety, and potential benefits of the investigational drug or treatment in a larger group of participants. The analysis should be conducted using appropriate statistical methods and should provide valuable insights for the subsequent phases of the clinical development plan. How will the Phase 2 trial data be analyzed? What specific endpoints and measures will be assessed? What challenges may arise during the data analysis and how can they be addressed? Resources or tools that may be helpful for this task include statistical analysis software, data visualization tools, and expert opinions. \n <\/div> \n <div class=\"textarea-field-content form-field-content\"> \n  <div class=\"form-group\"> <label> Phase 2 trial data analysis <\/label> <textarea placeholder=\"Something will be typed here...\" rows=\"3\" disabled class=\"form-control\"><\/textarea> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"approval-phase-2-trial-data\"> \n <h2>Approval: Phase 2 Trial Data<\/h2>\n <div class=\"approval-content\"> \n  <div class=\"header\"> \n   <div class=\"list-title\">\n    Will be submitted for approval:\n   <\/div> \n  <\/div> \n  <div class=\"approval-rule-subject-tasks-list\"> \n   <ul class=\"list\"> \n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Conduct Phase 2 trial<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li>\n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Analyze Phase 2 trial data<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li> \n   <\/ul> \n  <\/div> \n <\/div> \n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Identify target disease indication This task involves identifying the specific disease or condition that the clinical development plan will target. The goal is to determine the area of focus for the plan, which will guide the rest of the process. Consider the impact of choosing the right disease indication, the potential benefits to patients, and [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ep_exclude_from_search":false,"cover_icon_emoji":"\ud83d\udccb","cover_icon_url":"","tasks_count":"20","template_description":"","template_id":"uLWihezmovH1AZw7iGtOLA","task_0":"Identify target disease indication","task_slug_0":"identify-target-disease-indication","task_1":"Conduct literature review on target indication","task_slug_1":"conduct-literature-review-on-target-indication","task_2":"Assemble project team","task_slug_2":"assemble-project-team","task_3":"Develop clinical trial concept","task_slug_3":"develop-clinical-trial-concept","task_4":"Approval: Clinical Trial Concept","task_slug_4":"approval-clinical-trial-concept","task_5":"Design preliminary trial protocol","task_slug_5":"design-preliminary-trial-protocol","task_6":"Conduct pre-IND meeting with FDA","task_slug_6":"conduct-preind-meeting-with-fda","task_7":"Approval: Pre-IND Meeting outcomes","task_slug_7":"approval-preind-meeting-outcomes","task_8":"Prepare IND application","task_slug_8":"prepare-ind-application","task_9":"Submit IND application to FDA","task_slug_9":"submit-ind-application-to-fda","task_10":"Address any FDA questions regarding IND application","task_slug_10":"address-any-fda-questions-regarding-ind-application","task_11":"Receive FDA approval for IND application","task_slug_11":"receive-fda-approval-for-ind-application","task_12":"Prepare for Phase 1 trial","task_slug_12":"prepare-for-phase-1-trial","task_13":"Conduct Phase 1 trial","task_slug_13":"conduct-phase-1-trial","task_14":"Analyze Phase 1 trial data","task_slug_14":"analyze-phase-1-trial-data","task_15":"Approval: Phase 1 Trial Data","task_slug_15":"approval-phase-1-trial-data","task_16":"Prepare for Phase 2 trial","task_slug_16":"prepare-for-phase-2-trial","task_17":"Conduct Phase 2 trial","task_slug_17":"conduct-phase-2-trial","task_18":"Analyze Phase 2 trial data","task_slug_18":"analyze-phase-2-trial-data","task_19":"Approval: Phase 2 Trial Data","task_slug_19":"approval-phase-2-trial-data","task_20":"","task_slug_20":"","task_21":"","task_slug_21":"","task_22":"","task_slug_22":"","task_23":"","task_slug_23":"","task_24":"","task_slug_24":"","task_25":"","task_slug_25":"","task_26":"","task_slug_26":"","task_27":"","task_slug_27":"","task_28":"","task_slug_28":"","task_29":"","task_slug_29":"","task_30":"","task_slug_30":"","task_31":"","task_slug_31":"","task_32":"","task_slug_32":"","task_33":"","task_slug_33":"","task_34":"","task_slug_34":"","task_35":"","task_slug_35":"","task_36":"","task_slug_36":"","task_37":"","task_slug_37":"","task_38":"","task_slug_38":"","task_39":"","task_slug_39":"","task_40":"","task_slug_40":"","task_41":"","task_slug_41":"","task_42":"","task_slug_42":"","task_43":"","task_slug_43":"","task_44":"","task_slug_44":"","task_45":"","task_slug_45":"","task_46":"","task_slug_46":"","task_47":"","task_slug_47":"","task_48":"","task_slug_48":"","task_49":"","task_slug_49":"","task_50":"","task_slug_50":"","task_51":"","task_slug_51":"","task_52":"","task_slug_52":"","task_53":"","task_slug_53":"","task_54":"","task_slug_54":"","task_55":"","task_slug_55":"","task_56":"","task_slug_56":"","task_57":"","task_slug_57":"","task_58":"","task_slug_58":"","task_59":"","task_slug_59":"","task_60":"","task_slug_60":"","task_61":"","task_slug_61":"","task_62":"","task_slug_62":"","task_63":"","task_slug_63":"","task_64":"","task_slug_64":"","task_65":"","task_slug_65":"","task_66":"","task_slug_66":"","task_67":"","task_slug_67":"","task_68":"","task_slug_68":"","task_69":"","task_slug_69":"","task_70":"","task_slug_70":"","task_71":"","task_slug_71":"","task_72":"","task_slug_72":"","task_73":"","task_slug_73":"","task_74":"","task_slug_74":"","task_75":"","task_slug_75":"","task_76":"","task_slug_76":"","task_77":"","task_slug_77":"","task_78":"","task_slug_78":"","task_79":"","task_slug_79":"","task_80":"","task_slug_80":"","task_81":"","task_slug_81":"","task_82":"","task_slug_82":"","task_83":"","task_slug_83":"","task_84":"","task_slug_84":"","task_85":"","task_slug_85":"","task_86":"","task_slug_86":"","task_87":"","task_slug_87":"","task_88":"","task_slug_88":"","task_89":"","task_slug_89":"","task_90":"","task_slug_90":"","task_91":"","task_slug_91":"","task_92":"","task_slug_92":"","task_93":"","task_slug_93":"","task_94":"","task_slug_94":"","task_95":"","task_slug_95":"","task_96":"","task_slug_96":"","task_97":"","task_slug_97":"","task_98":"","task_slug_98":"","task_99":"","task_slug_99":"","footnotes":""},"categories":[29,113],"tags":[],"class_list":["post-32651","post","type-post","status-publish","format-standard","hentry","category-healthcare","category-medical"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/posts\/32651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/comments?post=32651"}],"version-history":[{"count":0,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/posts\/32651\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/media?parent=32651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/categories?post=32651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/tags?post=32651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}